Ignatia Amara Tablet
FDA Label NDC 54973-2916

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hyland's Inc. for the product Ignatia Amara (NDC 54973-2916). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, otc - do not use, otc - pregnancy or breast feeding, otc - ask doctor, otc - keep out of reach of children, otc - when using, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Otc - Active Ingredient

IGNATIA AMARA 30X

Otc - Do Not Use

Do not use if cap band is missing or broken.

Otc - Pregnancy Or Breast Feeding

If you are pregnant or nursing, consult a licensed health care professional before using this product.

Otc - Ask Doctor

If symptoms persist for 7 days or worsen, contact a licensed practitioner.

Otc - Keep Out Of Reach Of Children

Keep this and all medicines out of the reach of children.

Otc - When Using

To be used according to label indications and/or standard homeopathic indications.

Directions

Adults: Dissolve 4 tablets under tongue 4 times a day. Children: 2 tablets as above.

Inactive Ingredient

In a base of Acacia Gum and Lactose N.F.

Questions?

800-624-9659

* Please review the disclaimer below.